Page last updated: 2024-10-31

mofezolac and Abnormalities, Drug-Induced

mofezolac has been researched along with Abnormalities, Drug-Induced in 2 studies

mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit

Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.

Research Excerpts

ExcerptRelevanceReference
"Mofezolac (N-22) is a new developed analgesic and anti-inflammatory agent."1.28[Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration]. ( Fuchigami, K; Kodama, R; Matsunaga, K; Otsuka, T; Sameshima, K; Yamakita, O, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toteno, I1
Haguro, S1
Furukawa, S1
Morinaga, T1
Morino, K1
Fujii, S1
Yamakita, O2
Fuchigami, K1
Otsuka, T1
Sameshima, K1
Matsunaga, K1
Kodama, R1

Other Studies

2 other studies available for mofezolac and Abnormalities, Drug-Induced

ArticleYear
[Reproductive and developmental toxicity study of mofezolac (N-22) (2)--Study by oral administration of N-22 during the period of fetal organogenesis in rats].
    The Journal of toxicological sciences, 1990, Volume: 15 Suppl 2

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal;

1990
[Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration].
    The Journal of toxicological sciences, 1990, Volume: 15 Suppl 2

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal;

1990